Cargando…

A new mutation found in newborn screening for Fabry disease evaluated by plasma globotriaosylsphingosine levels

A pilot study of newborn screening for Fabry disease was performed in Okinawa, Japan. A total of 2,443 neonates were screened using dried blood spot samples over 7 years starting in 2007. Of 13 neonates determined to have low α-galactosidase A (GLA) activity, one boy had a new missense mutation, p.G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chinen, Yasutsugu, Nakamura, Sadao, Yoshida, Tomohide, Maruyama, Hiroki, Nakamura, Kimitoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Data Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5311055/ https://www.ncbi.nlm.nih.gov/pubmed/28224042 http://dx.doi.org/10.1038/hgv.2017.2

Ejemplares similares

Clinical significance of plasma globotriaosylsphingosine levels in Chinese patients with Fabry disease
por: Ouyang, Yan, et al.
Publicado: (2018)

Distinctive accumulation of globotriaosylceramide and globotriaosylsphingosine in a mouse model of classic Fabry disease
por: Taguchi, Atsumi, et al.
Publicado: (2023)

Plasma mutant α-galactosidase A protein and globotriaosylsphingosine level in Fabry disease
por: Tsukimura, Takahiro, et al.
Publicado: (2014)

Plasma Globotriaosylsphingosine and α-Galactosidase A Activity as a Combined Screening Biomarker for Fabry Disease in a Large Japanese Cohort
por: Maruyama, Hiroki, et al.
Publicado: (2021)

Migalastat HCl Reduces Globotriaosylsphingosine (Lyso-Gb(3)) in Fabry Transgenic Mice and in the Plasma of Fabry Patients
por: Young-Gqamana, Brandy, et al.
Publicado: (2013)

Additional findings of tibial dysplasia in a male with orofaciodigital syndrome type XVI
por: Chinen, Yasutsugu, et al.
Publicado: (2022)

Monitoring globotriaosylsphingosine in a Korean male patient with Fabry disease
por: Jang, Heejoon, et al.
Publicado: (2019)

A novel nonsense SMC1A mutation in a patient with intractable epilepsy and cardiac malformation
por: Chinen, Yasutsugu, et al.
Publicado: (2019)

Newborn screening for Fabry disease in the western region of Japan
por: Sawada, Takaaki, et al.
Publicado: (2020)

Pulmonary involvement in Fabry disease: effect of plasma globotriaosylsphingosine and time to initiation of enzyme replacement therapy
por: Franzen, Daniel, et al.
Publicado: (2018)

A novel homozygous missense SLC25A20 mutation in three CACT-deficient patients: clinical and autopsy data
por: Chinen, Yasutsugu, et al.
Publicado: (2020)

Does administration of hydroxychloroquine/amiodarone accelerate accumulation of globotriaosylceramide and globotriaosylsphingosine in Fabry mice?
por: Tsukimura, Takahiro, et al.
Publicado: (2021)

Globotriaosylsphingosine Accumulation and Not Alpha-Galactosidase-A Deficiency Causes Endothelial Dysfunction in Fabry Disease
por: Namdar, Mehdi, et al.
Publicado: (2012)

Detection of novel Fabry disease‐associated pathogenic variants in Japanese patients by newborn and high‐risk screening
por: Sawada, Takaaki, et al.
Publicado: (2020)

Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease
por: Sueoka, Hideaki, et al.
Publicado: (2015)

Newborn Screening for Pompe Disease
por: Sawada, Takaaki, et al.
Publicado: (2020)

Fabry disease screening in high-risk populations in Japan: a nationwide study
por: Yoshida, Shinichiro, et al.
Publicado: (2020)

High-Risk Screening for Fabry Disease: A Nationwide Study in Japan and Literature Review
por: Sawada, Takaaki, et al.
Publicado: (2021)

Descriptive Epidemiology of Fabry Disease Among Beneficiaries of the Specified Disease Treatment Research Program in Japan
por: Tsuboi, Kazuya, et al.
Publicado: (2012)

Hyperprolinemia type I caused by homozygous p.T466M mutation in PRODH
por: Hama, Rina, et al.
Publicado: (2021)

Analysis of Lyso-Globotriaosylsphingosine in Dried Blood Spots
por: Johnson, Britt, et al.
Publicado: (2013)

Newborn screening for Gaucher disease in Japan
por: Sawada, Takaaki, et al.
Publicado: (2022)

Isovaleric acidemia: Therapeutic response to supplementation with glycine, l-carnitine, or both in combination and a 10-year follow-up case study
por: Chinen, Yasutsugu, et al.
Publicado: (2017)

A Rapid and Simple UHPLC-MS/MS Method for Quantification of Plasma Globotriaosylsphingosine (lyso-Gb3)
por: Perrone, Alessandro, et al.
Publicado: (2021)

Newborn screening for Fabry disease in the north-west of Spain
por: Colon, Cristobal, et al.
Publicado: (2017)

Newborn Screening for Fabry Disease: Current Status of Knowledge
por: Gragnaniello, Vincenza, et al.
Publicado: (2023)

Late-onset ornithine transcarbamylase deficiency caused by a somatic mosaic mutation
por: Lee, Tomoko, et al.
Publicado: (2018)

Newborn screening for spinal muscular atrophy in Japan: One year of experience
por: Sawada, Takaaki, et al.
Publicado: (2022)

Clinical manifestations in two patients with pyruvate dehydrogenase deficiency and long-term survival
por: Yoshida, Takanobu, et al.
Publicado: (2017)

Mass Spectrometry Analysis of Globotriaosylsphingosine and Its Analogues in Dried Blood Spots
por: Boutin, Michel, et al.
Publicado: (2023)

Current status of newborn screening for Pompe disease in Japan
por: Sawada, Takaaki, et al.
Publicado: (2021)

Epithelial–Mesenchymal Transition in Kidney Tubular Epithelial Cells Induced by Globotriaosylsphingosine and Globotriaosylceramide
por: Jeon, Yeo Jin, et al.
Publicado: (2015)

Lyso-globotriaosylsphingosine induces endothelial dysfunction via autophagy-dependent regulation of necroptosis
por: Hwang, Ae-Rang, et al.
Publicado: (2023)

Mild prominence of the Sylvian fissure in a Bainbridge‐Ropers syndrome patient with a novel frameshift variant in ASXL3
por: Chinen, Yasutsugu, et al.
Publicado: (2017)

Frequency of iduronate-2-sulfatase gene variants detected in newborn screening for mucopolysaccharidosis type II in Japan
por: Hattori, Yusuke, et al.
Publicado: (2023)

Globotriaosylsphingosine (lyso-Gb3) might not be a reliable marker for monitoring the long-term therapeutic outcomes of enzyme replacement therapy for late-onset Fabry patients with the Chinese hotspot mutation (IVS4+919G>A)
por: Liu, Hao-Chuan, et al.
Publicado: (2014)

Characteristics of Neurological Symptoms in Adult Japanese Patients with Fabry Disease
por: Sawada, Jun, et al.
Publicado: (2021)

Newborn Screening for Fabry Disease in Northeastern Italy: Results of Five Years of Experience
por: Gragnaniello, Vincenza, et al.
Publicado: (2021)

Identification of a novel GLA mutation (F69 L) in a Japanese patient with late-onset Fabry disease
por: Umeda, Toshiko, et al.
Publicado: (2015)

A new multiplex analysis of glucosylsphingosine and globotriaosylsphingosine in dried blood spots by tandem mass spectrometry
por: Van Baelen, Amber, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lfecb824dpujh4f64aggmc9rso